Ace NURS 3100 Exam 1 in 2025 – Your Ultimate Nursing Adventure Starts Here!

During the New Drug Review step for a new therapeutic agent, the nurse is most likely to attend meetings to finalize the brand name for the drug. This activity is important as it involves ensuring that the drug is given an appropriate and marketable name that complies with regulatory guidelines.

Checking on the results of animal testing (option B) is typically done by researchers and scientists involved in pharmacology and preclinical trials. Evaluating the results of the drug on cultured cells (option C) is also usually done by researchers in laboratory settings. Surveying for harmful effects in a larger population (option D) is typically part of post-marketing surveillance and pharmacovigilance activities, which are often conducted by healthcare professionals post-approval of the drug.

Therefore, the most appropriate role for the nurse during the New Drug Review step is to attend meetings to finalize the brand name for the drug.